HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICMAD Attorney: ‘Bad’ Cosmetics Bill Won’t Get Through Senate, But Next Session Is Less Certain

Executive Summary

According to Locke Lord attorney Sharon Blinkoff, general counsel at ICMAD, Senate Health Committee Chair Lamar Alexander is inclined to block cosmetics reform legislation that lacks express industry support. She noted, however, that the Republican senator for Tennessee is retiring at the end of this term.

You may also be interested in...



'Could Put Us Out Of Business’: US State Bill Pileup Has Small Beauty Set On Federal Preemption

The cosmetics industry has an “optics” problem, and that is creating other issues, namely a growing body of state legislation to address perceived gaps in federal regulatory oversight.

Cosmetics Sector Needs Positive, Not Punitive, 21st Century Regulation – IBA

Independent Beauty Association president Ken Marenus discusses the trade group’s vision for modern, proportionate cosmetics regulation and forces at work that could undermine progress and endanger small businesses.

NGOs To Assert COVID-Unsafe Cosmetic Ingredients In Next US Legislative Reform Push

The Campaign for Safe Cosmetics, powered by Breast Cancer Prevention Partners and the Environmental Working Group, intends to present the 117th Congress with links between cosmetic ingredients and increased COVID susceptibility as part of its push for tighter cosmetics industry oversight.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148804

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel